These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6391140)

  • 1. Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy.
    Bedikian AY; Patt YZ; Murphy WK; Umsawasadi T; Carr DT; Hersh EM; Bodey GP; Valdivieso M
    Am J Clin Oncol; 1984 Oct; 7(5):399-404. PubMed ID: 6391140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.
    Salvati F; Rasi G; Portalone L; Antilli A; Garaci E
    Anticancer Res; 1996; 16(2):1001-4. PubMed ID: 8687090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
    Valdivieso M; Burgess MA; Ewer MS; Mackay B; Wallace S; Benjamin RS; Ali MK; Bodey GP; Freireich EJ
    J Clin Oncol; 1984 Mar; 2(3):207-14. PubMed ID: 6321689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
    Rapp E; Pater JL; Willan A; Cormier Y; Murray N; Evans WK; Hodson DI; Clark DA; Feld R; Arnold AM
    J Clin Oncol; 1988 Apr; 6(4):633-41. PubMed ID: 2833577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer.
    Scher HI; Shank B; Chapman R; Geller N; Pinsky C; Gralla R; Kelsen D; Bosl G; Golbey R; Petroni G
    Cancer Res; 1988 Mar; 48(6):1663-70. PubMed ID: 2830968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of non-small-cell cancer.
    Soukop M
    Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
    Murray N; Coppin C; Coldman A; Pater J; Rapp E
    J Clin Oncol; 1994 Nov; 12(11):2333-9. PubMed ID: 7964949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer.
    Umsawasdi T; Valdivieso M; Booser DJ; Barkley HT; Ewer M; MacKay B; Dhingra HM; Murphy WK; Spitzer G; Chiuten DF
    Cancer; 1989 Nov; 64(10):1995-2000. PubMed ID: 2553235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
    Holmes EC; Hill LD; Gail M
    Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
    Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
    Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimen.
    Murray N; Osoba D; Shah A; Page R; Karsai H; Little C
    J Natl Cancer Inst; 1991 Feb; 83(3):190-4. PubMed ID: 1846431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung.
    Shank B; Scher H; Hilaris BS; Pinsky C; Martin M; Wittes RE
    Cancer; 1985 Dec; 56(12):2771-8. PubMed ID: 2996747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
    Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
    Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancer.
    Chlebowski RT; Chlebowski JS; Herrold J; Richardson B; Ali I; Block JB; Oktay E
    Am J Clin Oncol; 1985 Apr; 8(2):157-61. PubMed ID: 3914840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.